UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry

Blood, 2014-08, Vol.124 (6), p.955-962

2014

Volltextzugriff (PDF)

Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism

Circulation (New York, N.Y.), 2014-01, Vol.129 (4), p.479-486

2014

Volltextzugriff (PDF)

Endovascular Creation of an Arteriovenous Fistula (endoAVF) for Hemodialysis Access: First Results

Cardiovascular and interventional radiology, 2017-10, Vol.40 (10), p.1545-1551

2017

Volltextzugriff (PDF)

Venous thromboembolism - update 2019

Therapeutische Umschau, 2018, Vol.75 (8), p.496

Werth, Sebastian

2018

Volltextzugriff (PDF)

Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry

European heart journal, 2014-07, Vol.35 (28), p.1888-1896

2014

Volltextzugriff (PDF)

Effectiveness and safety of rivaroxaban therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry

Thrombosis and haemostasis, 2016-05, Vol.115 (5), p.939

2016

Volltextzugriff (PDF)

Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry

Thrombosis and haemostasis, 2015-06, Vol.113 (6), p.1247

2015

Volltextzugriff (PDF)

Diagnosis and Treatment of Pulmonary Embolism in Challenging Populations

Hamostaseologie, 2018-05, Vol.38 (2), p.87

2018

Volltextzugriff (PDF)

Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants. Results from the Dresden NOAC registry

Thrombosis and haemostasis, 2015-11, Vol.114 (5), p.1076

2015

Volltextzugriff (PDF)

Superficial vein thrombosis treated for 45 days with rivaroxaban versus fondaparinux: rationale and design of the SURPRISE trial

Journal of thrombosis and thrombolysis, 2016-08, Vol.42 (2), p.197-204

2016

Volltextzugriff (PDF)

Treatment of Acute VTE with Rivaroxaban - Results of the Prospective Dresden Noac Registry (NCT01588119)

Blood, 2016-12, Vol.128 (22), p.2618-2618

2016

Volltextzugriff (PDF)

Acute Treatment Of Pulmonary Embolism With Rivaroxaban - Real Life Data From The Prospective Dresden Noac Registry (NCT01588119)

Blood, 2013-11, Vol.122 (21), p.2380-2380

2013

Volltextzugriff (PDF)

Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry

Thrombosis and haemostasis, 2013-01, Vol.109 (1), p.154

2013

Volltextzugriff (PDF)

Outpatient or inpatient treatment for acute pulmonary embolism: a retrospective cohort study of 439 consecutive patients

Journal of thrombosis and thrombolysis, 2015-07, Vol.40 (1), p.26-36

2015

Volltextzugriff (PDF)

Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs)

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2015-08, Vol.15 (4), p.235-242

2015

Volltextzugriff (PDF)

Characteristics of Atrial Fibrillation Patients Not Switched from Vka to Noac and Persistence on Vka – a Subgroup Analysis of the Prospective Dresden Noac Registry (NCT01588119)

Blood, 2014-12, Vol.124 (21), p.1538-1538

2014

Volltextzugriff (PDF)

Centrally Adjudicated Cause of Death during Noac Treatment – Results of the Prospective Dresden Noac Registry (NCT01588119)

Blood, 2014-12, Vol.124 (21), p.2876-2876

2014

Volltextzugriff (PDF)

Hospitalization or Outpatient Treatment for Acute Pulmonary Embolism - a Retrospective Cohort Study of 439 Consecutive Patients with Community-Aquired Pulmonary Embolism

Blood, 2012-11, Vol.120 (21), p.3416-3416

2012

Volltextzugriff (PDF)

Erratum to: Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs)

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2015-12, Vol.15 (6), p.451-452

2015

Volltextzugriff (PDF)

Real Life Efficacy and Safety of Dabigatran for Stroke Prevention in Atrial Fibrillation – Final Results of the Prospective Noac Registry (NCT01588119)

Blood, 2014-12, Vol.124 (21), p.1541-1541

2014

Volltextzugriff (PDF)

Regulation of endothelial barrier function during flow-induced conversion to an arterial phenotype

Cardiovascular research, 2007-08, Vol.75 (3), p.596-607

2007

Volltextzugriff (PDF)

Changes Of Coagulation Activation Parameters After Discontinuation Of VTE Treatment With Vitamin-K Antagonists, Apixaban, Rivaroxaban Or Dabigatran and Impact On Clinical Outcome After 12 Months

Blood, 2013-11, Vol.122 (21), p.3647-3647

2013

Volltextzugriff (PDF)

Pattern and Management Of Bleeding Complications With Novel Oral Anticoagulants – Results Of The Prospective Dresden Noac Registry (NCT01588119)

Blood, 2013-11, Vol.122 (21), p.214-214

2013

Volltextzugriff (PDF)

Trousseau's syndrome in a patient with adenocarcinoma of unknown primary and therapy‐resistant venous thrombosis treated with dabigatran and fondaparinux

British journal of clinical pharmacology, 2011-10, Vol.72 (4), p.715-716

2011

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry

Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism

Endovascular Creation of an Arteriovenous Fistula (endoAVF) for Hemodialysis Access: First Results

Venous thromboembolism - update 2019

Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry

Effectiveness and safety of rivaroxaban therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry

Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry

Diagnosis and Treatment of Pulmonary Embolism in Challenging Populations

Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants. Results from the Dresden NOAC registry

Superficial vein thrombosis treated for 45 days with rivaroxaban versus fondaparinux: rationale and design of the SURPRISE trial

Treatment of Acute VTE with Rivaroxaban - Results of the Prospective Dresden Noac Registry (NCT01588119)

Acute Treatment Of Pulmonary Embolism With Rivaroxaban - Real Life Data From The Prospective Dresden Noac Registry (NCT01588119)

Safety and feasibility of a diagnostic algorithm combining clinical probability, d-dimer testing, and ultrasonography for suspected upper extremity deep venous thrombosis: a prospective management study

Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry

Outpatient or inpatient treatment for acute pulmonary embolism: a retrospective cohort study of 439 consecutive patients

Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs)

Characteristics of Atrial Fibrillation Patients Not Switched from Vka to Noac and Persistence on Vka – a Subgroup Analysis of the Prospective Dresden Noac Registry (NCT01588119)

Centrally Adjudicated Cause of Death during Noac Treatment – Results of the Prospective Dresden Noac Registry (NCT01588119)

Hospitalization or Outpatient Treatment for Acute Pulmonary Embolism - a Retrospective Cohort Study of 439 Consecutive Patients with Community-Aquired Pulmonary Embolism

Erratum to: Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs)

Real Life Efficacy and Safety of Dabigatran for Stroke Prevention in Atrial Fibrillation – Final Results of the Prospective Noac Registry (NCT01588119)

Regulation of endothelial barrier function during flow-induced conversion to an arterial phenotype

Changes Of Coagulation Activation Parameters After Discontinuation Of VTE Treatment With Vitamin-K Antagonists, Apixaban, Rivaroxaban Or Dabigatran and Impact On Clinical Outcome After 12 Months

Pattern and Management Of Bleeding Complications With Novel Oral Anticoagulants – Results Of The Prospective Dresden Noac Registry (NCT01588119)

Trousseau's syndrome in a patient with adenocarcinoma of unknown primary and therapy‐resistant venous thrombosis treated with dabigatran and fondaparinux

Suchergebnisse filtern